Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Apogee Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 158 | 2 | 169 | +13 |
| Shares | 57.9M | 143.5K | 61.5M | +3.76M (+6.5%) |
| Value | $2.62B | $6.50M | $2.30B | −$313.4M (−12.0%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Apogee Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (21)
Institutions that held Apogee Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Logos Global Management LP | 300,000 | $13.6M |
| Cubist Systematic Strategies, LLC | 91,213 | $4.13M |
| Boxer Capital Management, LLC | 86,000 | $3.90M |
| Candriam Luxembourg S.C.A. | 85,661 | $3.88M |
| Schonfeld Strategic Advisors LLC | 70,766 | $3.21M |
| Ensign Peak Advisors, Inc | 69,750 | $3.16M |
| Neo Ivy Capital Management | 38,523 | $1.75M |
| Readystate Asset Management LP | 23,400 | $1.06M |
| Jump Financial, LLC | 20,867 | $945.3K |
| Verition Fund Management LLC | 19,477 | $882.3K |
| SG Americas Securities, LLC | 9,890 | $448.0K |
| Allianz Asset Management GmbH | 6,900 | $312.6K |
| STRS Ohio | 5,500 | $249.2K |
| AQR Capital Management LLC | 5,365 | $243.0K |
| Aigen Investment Management, LP | 4,767 | $215.9K |
| Optimize Financial Inc | 4,473 | $202.6K |
| Virtus ETF Advisers LLC | 1,604 | $72.7K |
| Smartleaf Asset Management LLC | 82 | $3.66K |
| Simplex Trading, LLC | 73 | $3.00K |
| Caitong International Asset Management Co., Ltd | 41 | $1.86K |
| Parallel Advisors, LLC | 6 | $272 |
Not filed for Q1 2025 yet (2)
Institutions that held Apogee Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 137,826 | $6.24M |
| AlphaCentric Advisors LLC | 5,649 | $255.9K |